Yahoo Web Search

Search results

1. • 

     Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb

     Motley Fool via Yahoo Finance· 7 days ago

     Still, Pfizer's upcoming bout with the patent cliff for key revenue generators like the...

2. • 

     USPTO Publishes Drug Patent and Exclusivity Study Report

     The National Law Review· 8 hours ago

     The U.S. Patent and Trademark Office (USPTO), in conjunction with the Food and Drug Administration...

3. • 

     Did Seagen Acquisition Help Pfizer Inc. (PFE) Increase Revenue in Q1?

     Insider Monkey via Yahoo Finance· 15 hours ago

     We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. In...

4. • 

     Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

     Zacks via Yahoo Finance· 11 hours ago

     Bristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted...

5. • 

     The Opaque Industry Secretly Inflating Prices for Prescription Drugs

     The New York Times via Yahoo News· 4 days ago

     Americans are paying too much for prescription drugs. It is a common, long-standing complaint. And...

6. • Overpaying for Medicine

     New York Times· 4 days ago

     You probably already know some of the reasons prescription drugs are so expensive. Health insurers and the government haven’t reined in prices. Your pharmacy benefit manager is often invisible ...

7. • 

     3 No-Brainer Stocks to Buy for Under $100 Right Now

     Motley Fool via Yahoo Finance· 3 days ago

     Bristol Myers' revenue growth has been slow, at best, ever since. There's more bad news coming. Opdivo, a cancer medicine currently among the company's...

8. • 

     Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?

     Investor's Business Daily· 4 days ago

     Last year, sales tumbled 42% to nearly $58.5 billion. Top sellers included Comirnaty and Paxlovid,...

9. • 

     Surviving The Summer’s Heat Wave - And Be Aware Of Medication Risks

     Forbes· 2 days ago

     This summer’s heat “dome” is brutal and could be deadly. Almost 80 million people in the US are...

10. • 

      US FDA approves Bristol Myers' colorectal cancer therapy

      Reuters· 3 days ago

      The approval under the agency's accelerated process was based on an early- to mid-stage study, in...